Potassium Chloride Pediatric Dose — Electrolyte Replacement
Potassium chloride (KCl) is an essential electrolyte supplement used to correct hypokalemia in pediatric patients by replenishing intracellular and extracellular potassium stores. It is classified as an electrolyte replacement agent and acts by restoring normal potassium gradients critical for cardiac, neuromuscular, and renal function. It is indicated for the treatment and prevention of hypokalemia across inpatient and outpatient pediatric settings, with the chloride salt being the standard formulation; the acetate salt may be selected when there is a concurrent metabolic acidosis or when chloride load is a clinical concern.
Pediatric Dosing
| Route | Dose | Frequency / Notes |
|---|---|---|
| IV | 0.5–1 mEq/kg/dose | Infuse over 1 hour; maximum 20 mEq/dose; cardiac monitoring required |
| Oral (PO) | 1 mEq/kg/dose | One to four times daily (1–4 mEq/kg/day total); usual starting replacement dose |
The potassium salt formulation (chloride vs. acetate) should be selected based on the clinical goal. The chloride salt is standard; consult institutional protocol for acetate substitution criteria.
Worked example — IV route (20 kg child): 20 kg × 0.5 mEq/kg = 10 mEq (low end) to 20 kg × 1 mEq/kg = 20 mEq (high end, which also equals the single-dose maximum). Infuse over 1 hour with continuous cardiac monitoring.
Worked example — Oral route (10 kg child): 10 kg × 1 mEq/kg/dose = 10 mEq per dose, given one to four times daily as directed by clinical response.
Indications and Clinical Context
Potassium chloride is indicated for the correction of hypokalemia, which may arise from poor intake, gastrointestinal losses (vomiting, diarrhea, nasogastric suction), renal wasting, or medication effects (e.g., loop and thiazide diuretics). In pediatric patients, hypokalemia can precipitate cardiac dysrhythmias, skeletal muscle weakness, and impaired renal concentrating ability. IV replacement is reserved for patients with moderate-to-severe hypokalemia, symptomatic presentations, or inability to tolerate oral therapy. Oral replacement is preferred for mild-to-moderate asymptomatic hypokalemia when the gastrointestinal tract is functional, as it carries a lower risk of rapid concentration-related adverse effects.
Ongoing monitoring of serum potassium levels, renal function, and concurrent electrolytes (particularly magnesium, which must be replete to achieve lasting potassium correction) guides dosing adjustments and duration of supplementation.
Administration and Monitoring
IV potassium chloride must be administered as a diluted infusion — never as an undiluted bolus — over a minimum of 1 hour per dose. Continuous cardiac monitoring is required during IV infusion to detect potassium-related dysrhythmias, including peaked T-waves, widened QRS, or bradyarrhythmias. The maximum single IV dose is 20 mEq, regardless of weight. Peripheral IV infusions may cause phlebitis and pain; higher concentrations should be delivered via a central venous catheter per institutional protocol.
- Route: IV (diluted infusion) or oral; route selected based on severity and clinical status
- Monitoring: Serum potassium before and after each IV dose; cardiac monitoring during IV infusion
- Adverse effects: Hyperkalemia, cardiac dysrhythmias (IV), GI irritation including nausea and abdominal discomfort (oral), infusion-site pain or phlebitis (peripheral IV)
- Key caution: Use with extreme caution in patients with renal impairment; consult institutional protocol for dose adjustments
- Salt selection: Chloride salt is standard; acetate salt may be used depending on clinical goal
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.